362 related articles for article (PubMed ID: 30768253)
1. Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges.
Vinogradov AA; Yin Y; Suga H
J Am Chem Soc; 2019 Mar; 141(10):4167-4181. PubMed ID: 30768253
[TBL] [Abstract][Full Text] [Related]
2. A gold mine for drug discovery: Strategies to develop cyclic peptides into therapies.
Jing X; Jin K
Med Res Rev; 2020 Mar; 40(2):753-810. PubMed ID: 31599007
[TBL] [Abstract][Full Text] [Related]
3. Designing Cell-Permeable Macrocyclic Peptides.
Appiah Kubi G; Dougherty PG; Pei D
Methods Mol Biol; 2019; 2001():41-59. PubMed ID: 31134566
[TBL] [Abstract][Full Text] [Related]
4. Heterocycles: Versatile control elements in bioactive macrocycles.
Soor HS; Appavoo SD; Yudin AK
Bioorg Med Chem; 2018 Jun; 26(10):2774-2779. PubMed ID: 29735427
[TBL] [Abstract][Full Text] [Related]
5. Recent Reports of Solid-Phase Cyclohexapeptide Synthesis and Applications.
Prior AM; Hori T; Fishman A; Sun D
Molecules; 2018 Jun; 23(6):. PubMed ID: 29912160
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Functional Macrocyclic Peptides by Means of the RaPID System.
Tsiamantas C; Otero-Ramirez ME; Suga H
Methods Mol Biol; 2019; 2001():299-315. PubMed ID: 31134577
[TBL] [Abstract][Full Text] [Related]
7. Design, Properties and Recent Application of Macrocycles in Medicinal Chemistry.
Ermert P
Chimia (Aarau); 2017 Oct; 71(10):678-702. PubMed ID: 29070413
[TBL] [Abstract][Full Text] [Related]
8. Targeting of extracellular protein-protein interactions with macrocyclic peptides.
Taguchi S; Suga H
Curr Opin Chem Biol; 2021 Jun; 62():82-89. PubMed ID: 33774472
[TBL] [Abstract][Full Text] [Related]
9. Cell-permeable chameleonic peptides: Exploiting conformational dynamics in de novo cyclic peptide design.
Ramelot TA; Palmer J; Montelione GT; Bhardwaj G
Curr Opin Struct Biol; 2023 Jun; 80():102603. PubMed ID: 37178478
[TBL] [Abstract][Full Text] [Related]
10. Enhancing the Cell Permeability and Metabolic Stability of Peptidyl Drugs by Reversible Bicyclization.
Qian Z; Rhodes CA; McCroskey LC; Wen J; Appiah-Kubi G; Wang DJ; Guttridge DC; Pei D
Angew Chem Int Ed Engl; 2017 Feb; 56(6):1525-1529. PubMed ID: 28035784
[TBL] [Abstract][Full Text] [Related]
11. Lead discovery and optimization strategies for peptide macrocycles.
Bhat A; Roberts LR; Dwyer JJ
Eur J Med Chem; 2015 Apr; 94():471-9. PubMed ID: 25109255
[TBL] [Abstract][Full Text] [Related]
12. Macrocycles as protein-protein interaction inhibitors.
Dougherty PG; Qian Z; Pei D
Biochem J; 2017 Mar; 474(7):1109-1125. PubMed ID: 28298556
[TBL] [Abstract][Full Text] [Related]
13. Discovery and optimization of peptide macrocycles.
White AM; Craik DJ
Expert Opin Drug Discov; 2016 Dec; 11(12):1151-1163. PubMed ID: 27718641
[TBL] [Abstract][Full Text] [Related]
14. Immobilization and Intracellular Delivery of Circular Proteins by Modifying a Genetically Incorporated Unnatural Amino Acid.
Bi X; Yin J; Hemu X; Rao C; Tam JP; Liu CF
Bioconjug Chem; 2018 Jul; 29(7):2170-2175. PubMed ID: 29870654
[TBL] [Abstract][Full Text] [Related]
15. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
[TBL] [Abstract][Full Text] [Related]
16. Macrocyclic peptides: Tying up loose ends.
Saito F; Bode JW
Nat Chem; 2016 Nov; 8(12):1085-1086. PubMed ID: 27874868
[No Abstract] [Full Text] [Related]
17. Improving the passive permeability of macrocyclic peptides: Balancing permeability with other physicochemical properties.
Thansandote P; Harris RM; Dexter HL; Simpson GL; Pal S; Upton RJ; Valko K
Bioorg Med Chem; 2015 Jan; 23(2):322-7. PubMed ID: 25533323
[TBL] [Abstract][Full Text] [Related]
18. Strategies to Enhance Metabolic Stabilities.
Khatri B; Nuthakki VR; Chatterjee J
Methods Mol Biol; 2019; 2001():17-40. PubMed ID: 31134565
[TBL] [Abstract][Full Text] [Related]
19. Targeting "Undruggable" Proteins: Design of Synthetic Cyclopeptides.
Russo A; Aiello C; Grieco P; Marasco D
Curr Med Chem; 2016; 23(8):748-62. PubMed ID: 26758797
[TBL] [Abstract][Full Text] [Related]
20. Macrocyclization strategies for cyclic peptides and peptidomimetics.
Bechtler C; Lamers C
RSC Med Chem; 2021 Aug; 12(8):1325-1351. PubMed ID: 34447937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
